When tasked with a Phase III clinical trial for pulmonary arterial hypertension (PAH), Worldwide leveraged cutting-edge recruitment and retention strategies to overcome study challenges. From regionally tailored recruitment methods to partnering with patient advocacy organizations, our personalized approach resulted in an impressive 128% increase in global monthly enrollment.
Discover how our innovative solutions made a difference in this complex study and read the full case study to see how Worldwide’s expertise can help you drive success in your next oncology clinical trial.
